芳香化酶P450在子宫内膜异位症中的表达及意义

目的：探讨芳香化酶P450在子宫内膜异位症发病中的作用。其阳性表达用于诊断子宫内膜异位症可行性。方法：应用免疫组化方法检测正常子宫内膜和子宫内膜异位症的在位及异位内膜芳香化酶P450的表达。结果：芳香化酶P450在正常子宫内膜无表达或弱阳性，在子宫内膜异位症的在位和异位内膜均有强表达，且增殖期高于分泌期表达，敏感度为92％，特异度为95．5％。结论：子宫内膜芳香化酶分泌增加促进子宫内膜异位症的发生，并对其诊断有重要意义。     

海洋岩虫抗菌肽筛选及抗癌活性的初步研究

将岩虫匀浆液经反相浓缩、凝胶过滤和亲和柱层析获得活性组分，在体外用MTS／PMS(氮兰四唑盐／吩嗪硫酸甲酯)方法筛选抗菌肽，再分别用MTS／PMS方法和ELISA—AFP(甲胎蛋白)方法检测其对人肝癌细胞株HepG2增殖、AFP分泌及对正常大鼠成骨细胞株MC3T3-E1增殖的影响。结果表明，纯化的岩虫抗菌肽为组成型碱性蛋白(MW8．1kDa，pI8．6)，不同浓度抗菌肽对肝癌细胞增殖和AFP的分泌均有抑制作用，抑制作用大小与抗菌肽浓度呈正相关性；对正常成骨细胞未见明显的抑制和杀伤作用。     

A continuous fluorometric assay for phospholipase A(2) activity in brain cytosol

Alterations in phospholipase A₂ (PLA₂) activity have been implicated in Alzheimer disease and other neurological disorders, although brain PLA₂ activity is currently measured using lengthy, non-continuous assays. We describe herein a rapid, continuous assay in which we measured PLA₂ activity in mouse brain cytosol (CB-57). Brains were homogenized in HEPES buffer (pH 7.5) and the cytosolic fraction was prepared by centrifugation at 25 000×g for 20 min, followed by centrifugation of the supernatant at 100 000×g for 60 min. Cytosolic protein content was determined using the Bradford assay. Pyrene labeled phosphatidylcholine was added to 50 μg of cytosolic protein in Tris buffer (pH 8.0) containing fatty acid free-bovine serum albumin for a final assay volume of 2 ml. Assay temperature was maintained at 30±1°C. The excitation wavelength was 345 nm and emission was measured at 377 nm. Fluorescence intensity was converted to molar concentrations using a standard curve. Under these conditions, bromoenol lactone inhibited up to 58% of the PLA₂ activity with an IC₅₀ of 0.5 μM. In a separate experiment, lack of appreciable alternative acylhydrolase activity was verified chromatographically. Using this method, brain PLA₂ activity can be measured in a continuous, rapid, and sensitive manner.     

应用微柱凝胶法鉴定婴儿ABO及Rh（D）血型

目的 :比较传统试管法和微柱凝胶法全自动血型系统鉴定婴儿ABO及Rh(D)血型的研究。方法 :选取500份婴儿脐带血标本 ,采用试管法和微柱凝胶法进行ABO和Rh(D)血型 ,并选项取40份抗原性减弱的标本采用两种方法比较。结果 :在鉴定婴儿ABO和Rh(D)血型时两种方法差异无显著性。结论 :微柱凝胶法可取代试管法用于婴儿的ABO和Rh(D)血型鉴定。     

细菌受体分析在禽类血清四环素族残留物检测中的应用

目的:以商售 Charm 细菌四环素族受体与四环素族的特异性结合反应为基础,应用其对活体禽类动物血清中四环素族抗生素残留总量进行快速筛选,重点对方法的灵敏度、选择性、基质影响和准确性等进行综合评价。方法:血清经缓冲液稀释,其中的四环素族抗生素残留与~3H 标记的金霉素竞争结合特异性细菌受体。竞争反应温育时间5 min,温度35℃。3300r·min~(-1),5 min 离心分离倾去未结合的游离化合物,复合物沉淀用水溶解,加入闪烁液混匀后放置1 min,进行[~3H]通道的60s 液体闪烁计数。结果:在大于95%的置信水平,血清中四环素、土霉素和金霉素的检测低限分别为80,55,15μg·L~(-1);样本测试表明筛选水平为200μg·L~(-1)时,假阴性率为0,阳性检出结果中假阳性率不超过15%。结论:与色谱法相比,其快速、灵敏、选择性高,可对活体禽类动物血清中四环素族残留物进行高通量筛选。     

Hérida Regina Nunes SALGADO,et al:Microbiological assay for the determination of azithromycin in ophthalmic solutionsMicrobiological assay for the determination of azithromycin in ophthalmic solutions

IntroductionAzithromyciniscommercializedbypharmaciesinBrazilinophthalmicsolutionform. Despitetheproveneffectivenessandsafetyinitstreatment, thisdrug,untilthen, doesnotpossessamethodologyofstandar dizedanalysisforophthalmicsolutionsinofficialcom pendiumsan…     

丙磺舒对阿莫西林在家兔体内的药动学影响

目的:观察丙磺舒对阿莫西林在健康家兔体内药动学的影响.方法:采用微生物杯碟法测定兔血清中阿莫西林的浓度.结果:阿莫西林单剂量肌内注射后,吸收迅速,Tmax=(0.78±0.09)h,Cmax=(0.87±0.30)μg·mL-1,其代谢模型为一级速率一房室模型.当阿莫西林和丙磺舒等剂量伍用时丙磺舒对阿莫西林药动学参数的影响达到最大值:阿莫西林的t1/2由(2.06±0.09)h延长至(5.50±0.52)h,AUC由(4.07±0.05)μg·mL-1·h增加至(13.75±3.09)μg·mL-1·h,Cmax由(0.87±0.30)μg·mL-1增加至(6.30±1.46)μg·mL-1,且三者统计学差异极显著(P<0.01).结论:丙磺舒对阿莫西林的药动学参数的影响呈S型,当两者等剂量伍用时影响最大.     

Inactivation Methods for Experimental Nipah Virus Infection

Nipah virus (NiV) is an emerging zoonotic paramyxovirus that causes severe disease in humans and livestock. Due to its high pathogenicity in humans and the lack of available vaccines and therapeutics, NiV needs to be handled in biosafety level 4 (BSL-4) laboratories. Safe inactivation of samples containing NiV is thus necessary to allow further processing in lower containment areas. To date, there is only limited information available on NiV inactivation methods validated by BSL-4 facilities that can be used as a reference. Here, we compare some of the most common inactivation methods in order to evaluate their efficacy at inactivating NiV in infected cells, supernatants and organs. Thus, several physical and chemical inactivation methods, and combinations thereof, were assessed. Viral replication was monitored for 3 weeks and NiV presence was assessed by RT-qPCR, plaque assay and indirect immunofluorescence. A total of nineteen methods were shown to reduce NiV infectious particles in cells, supernatants and organs to undetectable levels. Therefore, we provide a list of methods for the safe and efficient inactivation of NiV.     

补肾化瘀解毒方药对肺癌耐药细胞的耐药逆转及机制研究

目的 :探讨补肾化瘀解毒方对肺癌耐药细胞的耐药逆转和逆转机制。方法 :选择人肺腺癌 A5 4 9、A5 4 9/DDP细胞株 ,采用细胞毒试验 (MTT)和流式细胞仪法 (FCM) ,分别观察补肾化瘀解毒方荷瘤动物血清对A5 4 9/DDP细胞的细胞毒和耐药逆转作用 ,以及对 A 5 4 9/DDP细胞肺耐药蛋白 L RP- 5 6的表达、耐药细胞内游离Ca2 +浓度等指标的影响。结果 :补肾化瘀解毒方含药血清对肺癌 A5 4 9/DDP耐药细胞有细胞毒作用和增强A5 4 9/DD对顺铂 (DDP)的敏感性 ,并能显著抑制肺耐药蛋白 L RP的表达 (P<0 .0 1) ,降低细胞内 Ca2 +浓度(P<0 .0 0 1)。结论 :补肾化瘀解毒方药物血清对化疗药物具有增敏和化疗耐药逆转作用 ,其机制与抑制肺癌耐药细胞耐药基因表达 ,阻止肺癌耐药细胞内 ca2 +的内流或释放有密切的关系     

中药黄曲霉毒素B1的含量考察

为制定中药ＡＦ－Ｂ１含量限度提供依据。方法：间接竞酶联免疫吸附法。结果：样品ＡＦ－Ｂ１含量在１．１４－３．７２μｇ／ｋｇ之间。结论：制定中药ＡＦ－Ｂ１含量限度是必要的。